1993
DOI: 10.1073/pnas.90.5.1839
|View full text |Cite
|
Sign up to set email alerts
|

Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.

Abstract: Transcription of type 1 human immunodeficiency virus (HIV-1) provirus is governed by the viral long terminal repeat (LTR). Drugs can block HIV-1 replication by inhibiting activity of its LTR. We report that topotecan, beta-lapachone, and curcumin are potent and selective inhibitors of HIV-1 LTR-directed gene expression, at concentrations that have minor effects on cells. At these concentrations, each drug inhibited p24 antigen production in cells either acutely or chronically infected with HIV-1. Their target … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
113
0
4

Year Published

2001
2001
2017
2017

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 203 publications
(118 citation statements)
references
References 21 publications
1
113
0
4
Order By: Relevance
“…Thus, compounds that block activation of HIV-1 are of therapeutic potential for extension of latency or inhibition of progressive HIV-1 infection (41). Additionally, for the first time, we have shown here the activation of p38 MAP kinase and JNK1 and -2 by SJW.…”
Section: Discussionmentioning
confidence: 61%
“…Thus, compounds that block activation of HIV-1 are of therapeutic potential for extension of latency or inhibition of progressive HIV-1 infection (41). Additionally, for the first time, we have shown here the activation of p38 MAP kinase and JNK1 and -2 by SJW.…”
Section: Discussionmentioning
confidence: 61%
“…[137] One study showed curcumin to be an effective compound to inhibit the HIV-1 LTR-directed gene expression without any major effects on cell viability. [138] It was also found that curcumin and its derivatives, specifically, reduced curcumin, allyl-curcumin, and tocopheryl-curcumin, discovered 70-85% inhibition in Tat protein transactivation of HIV-1 LTR measured by β-galactosidase activities of HeLa cells which in HIV-1 LTR was fused to the indictor of lac Z gene. [139] Furthermore, curcumin reserved the acetylation of Tat protein of HIV significantly by p300 related with invasion of HIV-1 multiplication.…”
Section: Antiviral Effectmentioning
confidence: 99%
“…Curcumin (diferuloylmethane), the yellow pigments in T that is widely used as a food coloring (curry) and preservative has been extensively studied. In particular, Cu inhibited purified human immunodeficiency virus type 1 (HIV-1) integrase [5,6], HIV-1 and HIV-2 proteases [7], and HIV-1 long terminal repeatdirected gene expression of acutely or chronically infected HIV-1 cells [8]. Cu also inhibited lipopolysaccharide (LPS)-induced activation of nuclear factor kappa B, a factor involved in the activation and replication of HIV-1 [9].…”
Section: Introductionmentioning
confidence: 99%